National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease

Nephrology ◽  
2017 ◽  
Vol 23 (1) ◽  
pp. 53-59
Author(s):  
Siribha Changsirikulchai ◽  
Pornpen Sangthawan ◽  
Jirayut Janma ◽  
Nintita Sripaiboonkij ◽  
Suthee Rattanamongkolgul ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Cardiovascular Risk Factors ◽  
National Survey ◽  
Survey Evaluation

Effects of aleglitazar on cardiovascular risk factors in patients with stage 3 chronic kidney disease and type 2 diabetes

2013 ◽  
Vol 231 (2) ◽  
pp. e3
Author(s):  
Matthias Herz ◽  
Klas Malmberg ◽  
Markolf Hanefeld ◽  
Luis Ruilope ◽  
A. Michael Lincoff ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Cardiovascular Risk Factors

scholarly journals Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes

2012 ◽  
Vol 36 (6) ◽  
pp. 433 ◽  
Author(s):  
Qing-Lin Lou ◽  
Xiao-Jun Ouyang ◽  
Liu-Bao Gu ◽  
Yong-Zhen Mo ◽  
Ronald Ma ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Cardiovascular Risk Factors

scholarly journals Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease status

2013 ◽  
Vol 10 (6) ◽  
pp. 505-513 ◽  
Author(s):  
Nathan D Wong ◽  
Christopher Patao ◽  
Kalina Wong ◽  
Shaista Malik ◽  
Stanley S Franklin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Disease Status

scholarly journals Contribution of Non Traditional Cardiovascular Risk Factors to the Cardiovascular Disease in Patient with Type 2 Diabetes

2020 ◽  
Vol 0 (0) ◽  
pp. 1-10
Author(s):  
Huda Ammar Al Trabulsi ◽  
Mohamed El-Shaer ◽  
Mohamed El-Daydamony ◽  
Alaa El-Sayed
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors

Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease

2020 ◽  
Vol 166 ◽  
pp. 108334
Author(s):  
Michael P. Bancks ◽  
Ehimare Akhabue ◽  
Jamal S. Rana ◽  
Jared P. Reis ◽  
Pamela J. Schreiner ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Sex Differences ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Before And After ◽  
Incident Cardiovascular Disease

Testosterone Levels in Males with Type 2 Diabetes and Their Relationship with Cardiovascular Risk Factors and Cardiovascular Disease

2010 ◽  
Vol 7 (5) ◽  
pp. 1954-1964 ◽  
Author(s):  
Antonio Hernández-Mijares ◽  
Katherine García-Malpartida ◽  
Eva Solá-Izquierdo ◽  
Celia Bañuls ◽  
Milagros Rocha ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Testosterone Levels

scholarly journals Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization

2016 ◽  
Vol 7 (2) ◽  
pp. 96-103 ◽  
Author(s):  
Hanghang Wang ◽  
Patrick H. Pun ◽  
Lydia Kwee ◽  
Damian Craig ◽  
Carol Haynes ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Ejection Fraction ◽  
Cardiac Catheterization ◽  
Genetic Variants ◽  
Risk Variants

Background: While the association between APOL1 genetic variants and chronic kidney disease (CKD) has been established, their association with cardiovascular disease (CVD) is unclear. This study sought to understand CKD and cardiovascular risk conferred by APOL1 variants in a secondary cardiovascular prevention population. Methods: Two risk variants in APOL1 were genotyped in African-Americans (n = 1,641) enrolled in the CATHGEN biorepository, comprised of patients referred for cardiac catheterization at Duke University Hospital, Durham, NC, USA (2001-2010). Individuals were categorized as noncarriers (n = 722), heterozygote (n = 771), or homozygote carriers (n = 231) of APOL1 risk alleles. Multivariable logistic regression and Cox proportional hazards models adjusted for CVD risk factors were used to assess the association between APOL1 risk variants and prevalent and incident CKD, prevalent coronary artery disease (CAD), incident CVD events, and mortality. Results: The previously identified association between APOL1 variants and prevalent CKD was confirmed (OR: 1.85, 95% CI: 1.33-2.57, p = 0.0002). No statistically significant associations were detected between APOL1 variants and incident CKD or prevalent CAD, incident CVD events or mortality. Age, type 2 diabetes, and ejection fraction at baseline were significant clinical factors that predicted the risk of incident CKD in a subgroup analysis of APOL1 homozygous individuals. Conclusion:APOL1 genetic variants are not associated with CAD or incident CVD events in a cohort of individuals with a high burden of cardiometabolic risk factors. In individuals with homozygous APOL1 status, factors that predicted subsequent CKD included age, presence of type 2 diabetes, and ejection fraction at baseline.

Sign in / Sign up

Export Citation Format

Share Document